Logo

Course

HIV Lunch and Learn Series: HIV Updates from CROI 2024

Details

Published Date: 07/29/2024

Expiration Date: 04/08/2027

CE Credit: CME:1

Description

This course will ensure that clinicians will know be informed on the latest research and trends from the CROI conference 2024. Topics covered will include new treatment options, including injectables for people living with HIV, as well as long-acting agents for PrEP. Other cutting-edge research will also be presented.  

Presenter(s)

Antonio E. Urbina,MD

Antonio E. Urbina, MD is the Medical Director for the Mt. Sinai Institute for Advanced Medicine Downtown clinic in New York City. Dr. Urbina serves as a Medical Director for the Clinical Education Initiative of the New York State Department of Health AIDS Institute as well as Professor of Medicine at the Icahn School of School of Medicine at Mount Sinai. Since completing his residency in Internal Medicine at Saint Vincent Catholic Medical Center-Manhattan in 1995, Dr. Urbina has pioneered innovative educational programming for community-based clinics, hospitals, and public health departments. He has directed more than 10 HIV clinical trials research protocols. From 2007 to 2009, Dr. Urbina served on the Presidential Advisory Council on HIV/AIDS (PACHA) as well as Governor Cuomo’s Task Force to end the AIDS epidemic in New York State.

Learning Objectives

  • Review the latest data from CROI 2024 on the latest recommendations for ART in PLWH.
  • Describe the latest data on long-acting injectable (LAI) ART options.
  • Discuss the latest data from CROI 2024 on LAI for PrEP.

Continuing Education Credit Information